Literature DB >> 25783495

Thiol-mediated multiple mechanisms centered on selenodiglutathione determine selenium cytotoxicity against MCF-7 cancer cells.

Takao Tobe1, Koji Ueda, Motozumi Ando, Yoshinori Okamoto, Nakao Kojima.   

Abstract

Selenium (Se) is an essential antioxidative micronutrient but can exert cancer-selective cytotoxicity if the nutritional levels are too high. Selenodiglutathione (GSSeSG) is a primary Se metabolite conjugated with two glutathione (GSH) moieties. GSSeSG has been suggested to be an important molecule for cytotoxicity. Here, we propose the underlying mechanisms for the potent cytotoxicity of GSSeSG: cellular intake; reductive metabolism; production of reactive oxygen species; oxidative damage to DNA; apoptosis induction. GSSeSG rather than selenite decreased cell viability and induced apoptosis accompanied by increases in intracellular Se contents. Therefore, GSSeSG-specific cytotoxicity may be ascribed to its preferable incorporation. Base oxidation and strand fragmentation in genomic DNA preceded cell death, suggesting that oxidative stress (including DNA damage) is crucial for GSSeSG cytotoxicity. Strand breaks of purified DNA were caused by the coexistence of GSSeSG and thiols (GSH, cysteine, homocysteine), but not the oxidized form or non-thiol reductants. This implies the important role of intracellular thiols in the mechanism of Se toxicity. GSH-assisted DNA strand breaks were inhibited by specific scavengers for hydrogen peroxide or hydroxyl radicals. The GSSeSG metabolite selenide induced some DNA strand breaks without GSH, whereas elemental Se did so only with GSH. These observations suggest involvement of Fenton-type reaction in the absence of transition metals and reactivation of inert elemental Se. Overall, our results suggest that chemical interactions between Se and the sulfur of thiols are crucial for the toxicity mechanisms of Se.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25783495     DOI: 10.1007/s00775-015-1254-6

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  32 in total

1.  Separation and identification of selenotrisulfides in epithelial cell homogenates by LC-ICP-MS and LC-ESI-MS after incubation with selenite.

Authors:  Charlotte Gabel-Jensen; Bente Gammelgaard; Lars Bendahl; Stefan Stürup; Ole Jøns
Journal:  Anal Bioanal Chem       Date:  2005-12-03       Impact factor: 4.142

2.  Reduction of the selenotrisulfide derivative of glutathione to a persulfide analog by glutathione reductase.

Authors:  H E Ganther
Journal:  Biochemistry       Date:  1971-10-26       Impact factor: 3.162

3.  Tumor-selective killing by selenite in patient-matched pairs of normal and malignant prostate cells.

Authors:  B Husbeck; L Nonn; D M Peehl; S J Knox
Journal:  Prostate       Date:  2006-02-01       Impact factor: 4.104

4.  Purification of genomic DNA from human whole blood by isopropanol-fractionation with concentrated Nal and SDS.

Authors:  L Wang; K Hirayasu; M Ishizawa; Y Kobayashi
Journal:  Nucleic Acids Res       Date:  1994-05-11       Impact factor: 16.971

Review 5.  Bioavailability of selenium from foods.

Authors:  John W Finley
Journal:  Nutr Rev       Date:  2006-03       Impact factor: 7.110

6.  The selenium metabolite selenodiglutathione induces cell death by a mechanism distinct from H2O2 toxicity.

Authors:  L Wu; J Lanfear; P R Harrison
Journal:  Carcinogenesis       Date:  1995-07       Impact factor: 4.944

7.  Selenium: biochemical role as a component of glutathione peroxidase.

Authors:  J T Rotruck; A L Pope; H E Ganther; A B Swanson; D G Hafeman; W G Hoekstra
Journal:  Science       Date:  1973-02-09       Impact factor: 47.728

8.  Selenite-mediated production of superoxide radical anions in A549 cancer cells is accompanied by a selective increase in SOD1 concentration, enhanced apoptosis and Se-Cu bonding.

Authors:  Claire M Weekley; Gloria Jeong; Michael E Tierney; Farjaneh Hossain; Aung Min Maw; Anu Shanu; Hugh H Harris; Paul K Witting
Journal:  J Biol Inorg Chem       Date:  2014-02-15       Impact factor: 3.358

9.  Selenium and selenoprotein deficiencies induce widespread pyogranuloma formation in mice, while high levels of dietary selenium decrease liver tumor size driven by TGFα.

Authors:  Mohamed E Moustafa; Bradley A Carlson; Miriam R Anver; Gerd Bobe; Nianxin Zhong; Jerrold M Ward; Christine M Perella; Victoria J Hoffmann; Keith Rogers; Gerald F Combs; Ulrich Schweizer; Glenn Merlino; Vadim N Gladyshev; Dolph L Hatfield
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

10.  Sodium selenide toxicity is mediated by O2-dependent DNA breaks.

Authors:  Gérald Peyroche; Cosmin Saveanu; Marc Dauplais; Myriam Lazard; François Beuneu; Laurence Decourty; Christophe Malabat; Alain Jacquier; Sylvain Blanquet; Pierre Plateau
Journal:  PLoS One       Date:  2012-05-07       Impact factor: 3.240

View more
  4 in total

1.  Responses of an American eel brain endothelial-like cell line to selenium deprivation and to selenite, selenate, and selenomethionine additions in different exposure media.

Authors:  Sophia R Bloch; John J Kim; Phuc H Pham; Peter V Hodson; Lucy E J Lee; Niels C Bols
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-09-22       Impact factor: 2.416

Review 2.  Therapeutic Benefits of Selenium in Hematological Malignancies.

Authors:  Melanie A Ehudin; Upendarrao Golla; Devnah Trivedi; Shobha D Potlakayala; Sairam V Rudrabhatla; Dhimant Desai; Sinisa Dovat; David Claxton; Arati Sharma
Journal:  Int J Mol Sci       Date:  2022-07-19       Impact factor: 6.208

3.  New Phosphoramidates Containing Selenium as Leishmanicidal Agents.

Authors:  Mikel Etxebeste-Mitxeltorena; Daniel Plano; Socorro Espuelas; Esther Moreno; Carlos Aydillo; Antonio Jiménez-Ruiz; Juan Carlos García Soriano; Carmen Sanmartín
Journal:  Antimicrob Agents Chemother       Date:  2021-08-02       Impact factor: 5.191

Review 4.  Selenium and selenoproteins: it's role in regulation of inflammation.

Authors:  Sneha Hariharan; Selvakumar Dharmaraj
Journal:  Inflammopharmacology       Date:  2020-03-06       Impact factor: 4.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.